$VTEX

do Carmo Thomaz Junior Geraldo sold $20K of VTEX

do Carmo Thomaz Junior Geraldo (Chief Executive Officer) sold 4,808 shares of VTEX (VTEX) at $4.22 on 2026-07-20 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · do Carmo Thomaz Junior Geraldo
Published Jul 21, 2026, 5:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 21, 2026, 5:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VTEX
Neutral
medium confidence
Mentioned
$VTEX
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VTEXNeutralLow
01

Why it matters

The disclosed sale amount ($20,289.76) is relatively small and, because it is under a pre-arranged 10b5-1 plan, it is less likely to represent new negative information about VTEX’s near-term prospects.

02

Market read

Primarily a sentiment/positioning datapoint for VTEX, with limited fundamental implications absent additional news.

03

What to watch

The article provides only the sale details, not context such as total planned volume, prior sales cadence, or whether the CEO also made purchases around the same period.

Relevance 2/10Novelty 3/10Timing: Filed 2026-07-21, disclosing a sale executed 2026-07-20.

Background

The article is an SEC Form 4 insider transaction disclosure for VTEX, reported as an open-market sale by the CEO.

Company-level read

Ticker impact

$VTEXNeutralMedium confidence
Context

SEC Form 4 shows CEO do Carmo Thomaz Junior Geraldo sold 4,808 shares of VTEX at $4.2200 on 2026-07-20 under a 10b5-1 plan.

Expected impact

Likely minimal price impact; any reaction should be short-lived unless accompanied by other company-specific news.

Evidence & confidence

The filing is a Form 4 insider transaction, but it explicitly states a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No sector read-across is provided; this is company-specific insider transaction data only.

None indicated.

None indicated.

Counterpoint

Traders may still view the sale as a mild negative signal if they believe 10b5-1 plans can coincide with changing risk perceptions, even if the plan is pre-arranged.

Key entities

  • VTEX

    Company whose CEO insider sale is disclosed on SEC Form 4.

  • do Carmo Thomaz Junior Geraldo

    VTEX CEO who sold 4,808 shares at $4.2200 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VTEXMed

VTEX (VTEX) Just Turned A Profit Corner, But Growth Is Slowing

VTEX (NYSE:VTEX) reported Q2 2026 results showing improved profitability with non-GAAP income from operations up 62.4% YoY to $13.8M, and free cash flow up 79.1% to $12.7M. However, revenue growth slowed to 1.3% YoY on an FX-neutral basis, with management expecting flat growth for Q3. The company repurchased 6.2M shares for $23.2M during the quarter.

$VTEXMedAI 8/10

VTEX (VTEX) Q2 2026 Earnings Call Transcript

VTEX reported Q2 2026 results in an earnings call. GMV was $5.7B, up 7% FX-neutral. Subscription revenue was $63.8M, up 1.3% FX-neutral. Non-GAAP operating income rose 62% to $13.8M, with a 21.4% margin. Free cash flow was $12.7M, up 79%. Q3 guidance calls for flat FX-neutral subscription growth.

$VTEXMedAI 8/10

VTEX Q2 Earnings Call Highlights

VTEX (NYSE:VTEX) reported Q2 margin and cash flow improvement and guided for Q3 and full-year low-single-digit FX-neutral subscription revenue growth and low-20% non-GAAP operating and free cash flow margins. Q2 non-GAAP subscription gross margin rose to 81.8%. Free cash flow rose 79% to $12.7M. VTEX repurchased 6.2M shares at $3.76.

$VTEXMed

VTEX (VTEX): Financial results for Q2 2026

VTEX (VTEX) furnished an SEC Form 6-K — earnings release. VTEX Reports Second Quarter 2026 Financial Results Subscription revenue grew 11.4% (+1.3% FXN), with GMV up 17.8% (+7.0% FXN) Non-GAAP income from operations increased 62.4% to US$13.8 million, reaching a 21.4% margin Free cash flow increased 79.1% to US$12.7 million, reaching a